Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

ClinicalTrials.gov ID: NCT00689273

Public ClinicalTrials.gov record NCT00689273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-WEEK, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, PHASE 2, MULTICENTER STUDY OF PF-04136309 IN SUBJECTS WITH OSTEOARTHRITIC PAIN OF THE KNEE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics in patients with osteoarthritic pain of the knee. The most painful knee joint will be identified as the index joint at screening, and this joint will be used for all pain assessments throughout the study.

Study identification

NCT ID
NCT00689273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 5, 2008 (Actual)
Primary completion
Nov 27, 2008 (Actual)
Completion
Nov 27, 2008 (Actual)
Last update posted
Jul 13, 2021

2008

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
University Clinical Research-DeLand, LLC DeLand Florida 32720 —
Arthritis & Rheumatic Care Center South Miami Florida 33143 —
Miami Research Associates South Miami Florida 33143 —
Diagnostic Imaging Centers Overland Park Kansas 66212 —
Vince and Associates Clinical Research Overland Park Kansas 66212 —
Commonwealth Biomedical Research, LLC Madisonville Kentucky 42431 —
Covenant Health and Wellness Center Chesterfield Missouri 63005 —
Metro Imaging St. Peters City of Saint Peters Missouri 63376 —
Metro Imaging West County Creve Coeur Missouri 63141 —
Analgesic Development Limited New York New York 10022-1009 —
New Horizons Clinical Research Cincinnati Ohio 45242 —
Omega Medical Research Warwick Rhode Island 02886 —
Statcare Warwick Rhode Island 02886 —
Diagnostics Research Group San Antonio Texas 78229 —
South Texas Radiology Group San Antonio Texas 78229 —
Commonwealth Orthopaedics and Rehabilitation PC Arlington Virginia 22205 —
IntegraTrials, LLC Arlington Virginia 22205 —
United Hospital Center Clinical Trials Office Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00689273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2021 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00689273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →